Ideal COVID-19 Vaccine for Indian International Travelers - M.A.Aleem Neurologist #Trichy #Tamilnadu #India

Ideal COVID-19 Vaccine for Indian International Travelers

   - M.A.Aleem Neurologist #Trichy #Tamilnadu #India 

The Government of India has approved three vaccines for use in India – Covishield (Oxford -AstraZeneca), Covaxin, and Sputnik. 

Eligible Indians  who have intention to travel abroad should produce  their Passport as ID for COVID-19 vaccination purpose.

 

Out of the three vaccines approved for use in India, only one—Covishield—features on the emergency use listing (EUL) of the World Health Organization (WHO). This listing is significant because many countries are now using it as a benchmark for allowing vaccinated foreign nationals to travel.

At present Covishield ( Oxford- AstraZeneca ) COVID-19 vaccine has been approved in

43 Countries which includes

Afghanistan,

Antigua and Barbuda,

Argentina,Bahrain,Bangladesh,

Barbados,Bhutan,

Bolivia, (Plurinational State of)

Botswana,Brazil,Cabo Verde,

Canada,Côte d'Ivoire,Dominica,

Egypt,Ethiopia,Ghana,Grenada,

Hungary,India,Jamaica,

Lebanon,Maldives,Morocco,

Myanmar,

Namibia,Nepal,Nicaragua,

Nigeria,Saint Kitts and Nevis,

Saint Lucia,

Saint Vincent and the Grenadines,Seychelles,

Solomon Islands,Somalia,

South Africa,Sri Lanka,

Suriname,The Bahamas,

Togo,Tonga,

Trinidad and Tobago and

Ukraine.

 Covaxin  vaccine against COVID-19 is presently approved in 9 countries like

Guyana,India,

Iran (Islamic Republic of),

Mauritius,Mexico,Nepal,

Paraguay,Philippines and

Zimbabwe.

So at present

Indians travelling abroad are desperately trying to get Covishield jabs as that is the only vaccine recognised by most nations.

It remains to be seen how things change once every nation has a vaccine passport requirement in place and if they will insist on passengers to have only been vaccinated by vaccines that are part of the host country’s list of approved vaccines. Or will nations come together to create a common vaccine list? Only time will tell.